Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Gutzmer
Friedegund Meier

Showing results (1-10 of 531) with videos related to

Pageof 54
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 15, 2021
Ralf Gutzmer, Friedegund Meier
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 29, 2015
[Update on BRAF and MEK inhibitors in the treatment of malignant melanoma]Ralf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Die Entwicklung der Therapie des Hautkrebses geht weiter - Bericht von der Jahrestagung der American Society of Clinical Oncology (ASCO) in Chicago vom 31.5.- 3.6. 2018Ralf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
3. Jahresauftakt-Tagung (JATT) der ADORalf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CTAntonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancer Treatment Reviews|August 1, 2020
Melanoma brain metastases - Interdisciplinary management recommendations 2020Ralf Gutzmer, Dirk Vordermark, Jessica C Hassel, et al.
Frontiers in Immunology|March 12, 2021
Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology CentersChristian D Sadik, Ewan A Langan, Ralf Gutzmer, et al.
Pageof 54

Showing results (1-10 of 531) with videos related to

Sort By:
Pageof 54
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 15, 2021
Ralf Gutzmer, Friedegund Meier
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 29, 2015
[Update on BRAF and MEK inhibitors in the treatment of malignant melanoma]Ralf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Die Entwicklung der Therapie des Hautkrebses geht weiter - Bericht von der Jahrestagung der American Society of Clinical Oncology (ASCO) in Chicago vom 31.5.- 3.6. 2018Ralf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
3. Jahresauftakt-Tagung (JATT) der ADORalf Gutzmer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CTAntonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancer Treatment Reviews|August 1, 2020
Melanoma brain metastases - Interdisciplinary management recommendations 2020Ralf Gutzmer, Dirk Vordermark, Jessica C Hassel, et al.
Frontiers in Immunology|March 12, 2021
Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology CentersChristian D Sadik, Ewan A Langan, Ralf Gutzmer, et al.
Pageof 54